Good news: is one dose of Pfizer really enough?


The results of a British study revealed, Friday, that a single dose of the Covid-19 vaccine, which is produced by Pfizer in partnership with Biontech, can significantly reduce the risk of infection.

Researchers analyzed the results of thousands of Covid-19 tests, which are conducted weekly as part of hospital examinations of medical teams in Cambridge, east England.

A third dose Earlier, scientists at the American company Pfizer and its German partner Biontech confirmed that they are examining the option of giving people a third dose of their vaccine.

And Pfizer stated, on Thursday, that the matter comes as part of its new strategy to protect humans from new strains of the Corona virus.

The health authorities say that the first generation of Corona virus vaccines is still effective against new versions of the epidemic, including the British and South African strains.

But manufacturers have begun to prepare for genetic mutations in the epidemic that are more resistant to vaccines.

The article expresses the opinion of its author and is not necessarily the site’s policy


Please enter your comment!
Please enter your name here